35 results on '"Döring G"'
Search Results
2. Innate immunity in cystic fibrosis lung disease
3. Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: A national overview
4. Three-dimensional human airway epithelial cell cultures
5. 75 Efficacy of inhaled antibiotics in CF patients with Pseudomonas aeruginosa (Pa) infection: a network meta-analysis (NMA)
6. 164 Neutrophil elastase-mediated increase in airway temperature during inflammation
7. WS6.2 Anti-inflammatory pulmonal therapy of CF patients with amitriptyline and placebo – a randomised, double-blind, placebo-controlled Phase IIb multicenter cohort study
8. WS11.5 Reversible proline hydroxylation in the guanylate cyclase SadC regulates alginate export in Pseudomonas aeruginosa
9. WS17.5 Increased apoptosis and lack of invariant NKT cells in patients with cystic fibrosis leads to circulating antinuclear antibodies
10. WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection
11. WS2.9 Expression and regulation of IFRD1 in neutrophils of cystic fibrosis patients
12. WS17.2 Anti-inflammatory therapy in a mouse model of Pseusomonas aeruginosa lung infection leads to bacteraemia
13. Post-translational regulation of alginate export by an oxygen sensor in Pseudomonas aeruginosa
14. Colistin/tobramycin combinations for killing of P. aeruginosa biofilms in cystic fibrosis: a pre-clinical and clinical in vivo study
15. EXPLOITING GENOMICS TO DEVELOP NEW ANTIBIOTICS AND VACCINES AGAINST CF-RELATED PATHOGENS
16. PSEUDOMONAS AERUGINOSA PATHOGENICITY WITHIN CLONAL STRAINS FROM PATIENTS WITH CYSTIC FIBROSIS
17. The respiratory burst of PMNs accelerates anaerobiosis in sputum from CF patients with chronic Pseudomonas aeruginosa lung infection
18. 87 Strict anaerobes persist in CF sputum despite antibiotic treatment
19. 86* Lactate production and Pseudomonas aeruginosa metabolism in CF sputum
20. 83 Emergence of an epidemic clone of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) Panton-Valentine leukocidin (PVL) negative in Cystic Fibrosis patients
21. 187 Diagnostic value of Pseudomonas aeruginosa antibodies in Cystic Fibrosis
22. 70 Pseudomonas aeruginosa in the oral cavity: implications for lung infection in patients with Cystic Fibrosis
23. 109 Efficacy of Temocillin in CF: a retrospective pilot study
24. 113 Clinical and immunodulatory effects of once weekly azithromycin treatment in Cystic Fibrosis patients chronically infected with Pseudomonas aeruginosa
25. 188 Combining microbiological culture, PCR and serology increases Pseudomonas aeruginosa diagnosis in CF
26. Nutrition in patients with cystic fibrosis: a European Consensus
27. A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
28. Lactate as a non-invasive marker of CF lung inflammation
29. Is 3-nitrotyrosine a marker of inflammation in airways of patients with cystic fibrosis?
30. Accumulation of NKT cells in tissues of cystic fibrosis mice
31. Impact of strict anaerobs on the pathogenesis of lung infection in patients with Cystic Fibrosis
32. Community-Acquired MRSA causes earlier infection than Hospital-Acquired MRSA in patients with cystic fibrosis
33. Characterization of SCC mec types involved in persistent MRSA infections in cystic fibrosis patients
34. Colistin sulfate/tobramycin combination is superior for killing biofilm P. aeruginosa than monotherapy in vitro
35. Origin of lactate in CF sputum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.